Across Health

About Across Health

Across Health helps biopharma companies make smarter go-to-market decisions by connecting omnichannel engagement and brand adoption within a uniquely comprehensive and competitive diagnostic framework...to drive real brand performance. Founded in 2007, we set out to give customer-focused teams a clear view of how healthcare professionals think, choose, and act in an increasingly complex, omnichannel world. Today, our Navigator365 product range is a trusted global reference for go-to-market intelligence. Our latest iteration of the Navigator365 Benchmark, called 4D (Data. Diagnostic. Deaveraged) offers a unique, end-to-end competitive brand health diagnostic linking how you and your direct competitors engage HCPs—across channels, content, and customer experience—to how they perceive and prescribe your brand. We don’t just report what’s happening—we partner with your team to uncover why, and translate insights into clear actions that drive impact. After joining Precision Medicine Group in 2021, Across Health returned to independence in June 2026 through a management buyout led by founder and CEO Fonny Schenck. Today, as Across Health 2.0, we are powering nearly two decades of evidence-based expertise with AI-first innovation to deliver faster, sharper, and more actionable decisions.